Toulouse University Hospital
🇫🇷France
Clinical Trials
751
Active:14
Completed:381
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:16
Phase 2:49
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (532 trials with phase data)• Click on a phase to view related trials
Not Applicable
407 (76.5%)Phase 2
49 (9.2%)Phase 4
34 (6.4%)Phase 3
25 (4.7%)Phase 1
16 (3.0%)Early Phase 1
1 (0.2%)Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke.
Not Applicable
Not yet recruiting
- Conditions
- StrokeCerebrovascular Disorders
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 18
- Registration Number
- NCT07084025
Non-interventional Study Exploring the Composition of the Valvular Microbiota of Patients Undergoing Cardiac Surgery
Not Applicable
Not yet recruiting
- Conditions
- ValvulopathyCardiac SurgeryMicrobiota
- Interventions
- Biological: Take 1 ml of bloodBiological: DNA sequencingProcedure: Valve collection (healthcare waste)Other: Collection of serious post-operative complications
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 200
- Registration Number
- NCT07075601
- Locations
- 🇫🇷
Rangueil Hospital, Toulouse, France
Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- ObesitySarcopeniaPost MenopauseType 2 DiabetesCircadian Clock
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 45
- Registration Number
- NCT07075133
- Locations
- 🇫🇷
Rangueil Hospital, Toulouse, France
Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment
Not Applicable
Active, not recruiting
- Conditions
- HIV (Human Immunodeficiency Virus)
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 30
- Registration Number
- NCT07062614
- Locations
- 🇫🇷
Infectious and Tropical Diseases Department, Purpan University Hospital, Toulouse Place du Docteur Baylac, Toulouse, France
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Not Applicable
Not yet recruiting
- Conditions
- Endometriosis
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 20
- Registration Number
- NCT07053982
- Locations
- 🇫🇷
Toulouse, Rangueil Hospital, Toulouse, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 150
- Next
News
Lixisenatide Shows Promise in Slowing Parkinson's Disease Progression in Phase 2 Trial
A Phase 2 trial of Sanofi's lixisenatide demonstrated the GLP-1 agonist's potential to halt motor symptom progression in Parkinson's disease patients over 12 months.